Presentation is loading. Please wait.

Presentation is loading. Please wait.

The Production of a Recombinant Biotechnology Product Chapter 8.

Similar presentations


Presentation on theme: "The Production of a Recombinant Biotechnology Product Chapter 8."— Presentation transcript:

1 The Production of a Recombinant Biotechnology Product Chapter 8

2 Objectives  Give a basic overview of genetic engineering.  Describe the processes involved in isolating a piece DNA of interest  Mass producing DNA or it’s protein product, and recovering product.  Describe how DNA concentrations and purity can be calculated.  Define cGMP.

3 8.1 Overview of Genetic Engineering  Genetic engineering involves the manipulation of the genetic information of an organism.  Genetic engineering can result in the production of organisms with new and improved characteristics.  Can bring about new and improved products.

4 Overview of Genetic Engineering  Steps in genetic engineering: 1.DNA or protein is identified or isolated.  In case of DNA a specific sequence is cut out and placed into a vector (produces recombinant DNA, rDNA). 2.Recombinant cells are produced.  Vector produced is inserted into a host cells. 3.Recombinant cells are grown in culture (cloning). 4.Recombinant protein product is isolated and purified.  Product is tested and sent to market.

5 Overview of Genetic Engineering

6 How do you find your gene of interest?  1. membrane removal  A. Bacterial chromosomal  B. Bacterial plasmids

7 How do you find your gene of interest?  A. Chromosomal:  Good amount of cells grown on agar or in broth culture  Cultures transferred to buffer solution contain enzyme lysozyme  Lysozyme degrades bacterial cell wall by breaking down structural carbohydrates  When cell walls gone….osmotic pressure causes cell to rupture dumping their cell contents

8 Cell Contents  Removing other molecules from the cell lysate.  Detergents  Dissolves membrane lipids and precipitates proteins.  Sarkosyl  SDS  Proteases  Remove proteins  RNase  Removes RNA

9 Cell Contents  Centrifugation  Spin sample  pellet (precipitate) forms at the bottom of the tube  Bacterial DNA remains in solution  Supernatant is poured off leaving debris pellet behind.  Cold ethanol extraction performed.  Layer cold ethanol applied followed by high-speed centrifuge spin.  Precipitated pellet that forms is DNA.

10 How do you find your gene of interest?  B. Plasmids:  Similar process to getting bacterial chromosomal DNA.  Exception: Cell lysis also contain a base such as, NaOH, in addition to using SDS  Allows for degradation of bacterial chromosomal DNA, In addition to cell wall and plasma membrane.  Requires a series of isopropanol and ethanol precipitations follow.  Isolating animal, plant, or fungal DNA is similar to bacterial chromosomal DNA with some minor differences.

11 8.2 Getting the DNA into a cell  Prior to getting DNA recombinant DNA (rDNA) needs to be produced.  Recombinant DNA can be created from putting your DNA of interest into a vector, or into the DNA of a virus.  Making recombinant DNA results from cutting your DNA and either the plasmid or viral DNA with restriction enzymes (molecular scissors)  Endonucleases  Isolated from bacteria  Named based on origin

12 Getting the DNA into a cell  The DNA cut and the vector it is inserted into have complementary base pairing ends.  These “sticky ends” are “glued” together using DNA ligase  Once successfully inserted the rDNA can be used.

13 Getting the DNA into a cell  Once you have your rDNA the next step is to get it into a cell or virus.

14 8.3 Producing Large Numbers of Transformed Cells  To get a protein or piece of DNA of interest you must have large volumes of transformed cells.  The process by which this is done is called scaling-up.  Transformed cells are grown in ever-increasing amounts, in larger and larger containers.  50 mL broth solution  1 or 2 L spinner flasks  10 L fermenters  100 L fermenters  1000 L fermenters  10,000 L or more fermenters  Bacteria exhibit exponential growth so under maximal conditions it generally does not take long for large volumes to be obtained from a seed colony.

15 Producing Large Numbers of Transformed Cells

16  During each scale-up the following variables are measured:  Cell growth rate  Product concentration  Product activity  Possible contamination

17 8.4 Producing Large Numbers of Transformed Cells  Clarifying fermentation.  Fermentation is “generally” defined as either:  Alcoholic fermentation (glucose into CO 2 and ethanol)  Lactic-acid fermentation (glucose into lactic acid)  In both cases cells utilize glucose under anaerobic conditions.  In biotechnology fermentation is defined as the growth of cells under optimum conditions for maximum cell division and product production.

18 8.5 Plasmid Retrieval from Cells  Plasmid retrieval is performed:  to make sure that the correct plasmid has been inserted into the cell.  to collect plasmids for future transformations.  Preparation (prep)  Extraction of plasmids from transformed cells.  Miniprep  Up to 20 µg/500 µL  Midipreps  800 µg/mL  Maxipreps  1 mg/mL or higher  Each process follows the same overall process but as larger amounts of plasmid are required larger volumes and equipment are needed.

19 Plasmid Retrieval from Cells  Outline of the miniprep procedure:  Transformed cells separated from the broth.  Resuspended cells are treated with high pH SDS- NaOH followed up with potassium acetate.  destroys cell wall and membrane  chromosomal DNA and proteins precipitate out  Mixture spun again and supernatant mixed with isopropanol.  Nucleic acids precipitate out.  Mixture spun again and ethanol washes preformed to remove everything except the DNA.  Your plasmid is in the pellet formed after the spin.  RNase may be added to limit chance of RNA contamination.  Plasmid pellet is resuspended in TE buffer.

20 Plasmid Retrieval from Cells  Determining the amount and the purity of your plasmid DNA.  Quick visual exam  Cut with restriction enzymes and run on gel electrophoresis.  Stain with ethidium bromide

21 Plasmid Retrieval from Cells  Determining the amount and the purity of your plasmid DNA.  UV spectroscopy  Measure at 260 nm  Usually want a minimum of 0.005 µg/µL  Restriction digest require a minimum concentration of 0.1 µg/µL.  How to calculate concentration?  Known that 50 µg/mL of pure double stranded DNA absorbs 1 au of light at 260 nm.  50 µg/mL = X µg/mL 1 au at 260 nm the absorbance of sample at 260 nm  Sample must have an absorbance of 0.02 to 2.0 au to be used.

22 Plasmid Retrieval from Cells  Determining the amount and the purity of your plasmid DNA.  UV spectroscopy  Calculating DNA purity  Must know the DNA & protein concentration  Use a ratio of DNA to protein to calculate  Absorbance (au) at 260 nm Absorbance (au) at 280 nm Absorbance (au) at 280 nm  Ratio value between 1.8 to 2.0 is desired  Greater than 2.0 RNA contamination.  Lesser than 1.8 protein contamination.  Purity values 1.0 or less indicate plasmids recovered not worth using for future transformations or restriction digest.

23 cGMP  Products that are produced and under FDA (Food and Drug Administration) must comply with current good manufacturing practices (cGMP).  cGMP is outlined in Title 21, Parts 210 and 211, of the Code of Federal Regulations.  Outlines quality management & organization, device design, buildings, equipment, purchase, and handling of components, production and process controls, packaging and labeling controls, device evaluation, distribution, installation, complaint handling, servicing, and record keeping.  Regular site audits are carried out by the FDA.

24 Homework 8  Section 8.1  Questions 2, 3, 4  Sec 8.2  Questions 2, 3  Think like biotech  Questions 1,3,4, 5, 7, 8

25 This project is funded by a grant awarded under the President’s Community Based Job Training Grant as implemented by the U.S. Department of Labor’s Employment and Training Administration (CB-15-162-06-60). NCC is an equal opportunity employer and does not discriminate on the following basis: against any individual in the United States, on the basis of race, color, religion, sex, national origin, age disability, political affiliation or belief; and against any beneficiary of programs financially assisted under Title I of the Workforce Investment Act of 1998 (WIA), on the basis of the beneficiary’s citizenship/status as a lawfully admitted immigrant authorized to work in the United States, or his or her participation in any WIA Title I-financially assisted program or activity. This product was funded by a grant awarded under the President’s High Growth Job Training Initiative, as implemented by the U.S. Department of Labor’s Employment & Training Administration. The information contained in this product was created by a grantee organization and does not necessarily reflect the official position of the U.S. Department of Labor. All references to non-governmental companies or organizations, their services, products, or resources are offered for informational purposes and should not be construed as an endorsement by the Department of Labor. This product is copyrighted by the institution that created it and is intended for individual organizational, non-commercial use only.


Download ppt "The Production of a Recombinant Biotechnology Product Chapter 8."

Similar presentations


Ads by Google